Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07075666

Early Detection of Prostate Cancer of Syrian Men

Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

the Detection of Prostate Cancer in Men

Age range

40 year–65 year

Sex eligibility

Male

Study type

Observational

Primary location

Al-Hawash Private University

Homs, 0000, Syria

About this study

This study aims to assess the awareness, attitudes, and practices regarding prostate cancer screening among men in the middle region of Syria, with the goal of identifying barriers to early detection and informing public health interventions.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men aged 40 years and older residing in the middle region of Syria.

Exclusion criteria

  • Men with a previous diagnosis of prostate cancer.

Treatment and study plan

PSA

Diagnostic Test

Prostate-Specific Antigen test, a blood test used to measure the level of PSA in a man's blood. PSA is a protein produced by the prostate gland, and elevated levels can indicate various conditions, including prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis.

DRE

Diagnostic Test

A digital rectal exam (DRE) is a procedure where a doctor inserts a lubricated, gloved finger into the rectum to check for abnormalities.

Primary outcomes

  1. Number of ptients with early signs of prostate cancer

    Time frame: From Participant enrolment to the end of the study at 2 weeks

Sponsors and collaborators

Lead sponsor

Al-Hawash Private University

Other

Registry information

Official study title

Early Detection of Prostate Cancer Among Men in the Middle Region of Syria

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 20, 2025
Registry last updated
Jul 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.